-
1
-
-
79958192032
-
Lipid-lowering drug therapy in elderly patients
-
Berthold HK, Gouni-Berthold I. Lipid-lowering drug therapy in elderly patients. Curr Pharm Des 2011; 17: 877-93.
-
(2011)
Curr Pharm Des
, vol.17
, pp. 877-893
-
-
Berthold, H.K.1
Gouni-Berthold, I.2
-
2
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
-
DOI 10.1016/S0140-6736(02)11600-X
-
Shepherd J, Blauw GJ, Murphy MB, et al.; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623-30. (Pubitemid 35379733)
-
(2002)
Lancet
, vol.360
, Issue.9346
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
Bollen, E.L.E.M.4
Buckley, B.M.5
Cobbe, S.M.6
Ford, I.7
Gaw, A.8
Hyland, M.9
Jukema, J.W.10
Kamper, A.M.11
Macfarlane, P.W.12
Meinders, A.E.13
Norrie, J.14
Packard, C.J.15
Perry, I.J.16
Stott, D.J.17
Sweeney, B.J.18
Twomey, C.19
Westendorp, R.G.J.20
more..
-
3
-
-
0344653659
-
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
-
Miettinen TA, Pyorala K, Olsson AG, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997; 96: 4211-8. (Pubitemid 28007446)
-
(1997)
Circulation
, vol.96
, Issue.12
, pp. 4211-4218
-
-
Miettinen, T.A.1
Pyorala, K.2
Olsson, A.G.3
Musliner, T.A.4
Cook, T.J.5
Faergeman, O.6
Berg, K.7
Pedersen, T.8
Kjekshus, J.9
-
4
-
-
14444271787
-
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trial
-
Lewis SJ, Moye LA, Sacks FM, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med 1998; 129: 681-9. (Pubitemid 28507140)
-
(1998)
Annals of Internal Medicine
, vol.129
, Issue.9
, pp. 681-689
-
-
Lewis, S.J.1
Moye, L.A.2
Sacks, F.M.3
Johnstone, D.E.4
Timmis, G.5
Mitchell, J.6
Limacher, M.7
Kell, S.8
Glasser, S.P.9
Grant, J.10
Davis, B.R.11
Pfeffer, M.A.12
Braunwald, E.13
-
5
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-57.
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
6
-
-
34447274822
-
Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease
-
Wenger NK, Lewis SJ, Herrington DM, Bittner V, Welty FK; Treating to New Targets Study Steering Committee and Investigators. Outcomes of using high- or low-dose atorvastatin in patients 65 s of age or older with stable coronary heart disease. Ann Intern Med 2007; 147: 1-9. (Pubitemid 351664628)
-
(2007)
Annals of Internal Medicine
, vol.147
, Issue.1
, pp. 1-9
-
-
Wenger, N.K.1
Lewis, S.J.2
Herrington, D.M.3
Bittner, V.4
Welty, F.K.5
-
7
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
8
-
-
84880047072
-
In patients with chronic stable angina, secondary prevention appears better in the very old compared to younger patients: The Coronary Artery Disease in gENeral practiCE (CADENCE) Substudy
-
Epub ahead of print
-
Rajendran S, Visvanathan R, Tavella R, Weekes AJ, Morgan C, Beltrame JF. In patients with chronic stable angina, secondary prevention appears better in the very old compared to younger patients: The Coronary Artery Disease in gENeral practiCE (CADENCE) Substudy. Heart Lung Circ 2012 Epub ahead of print.
-
(2012)
Heart Lung Circ
-
-
Rajendran, S.1
Visvanathan, R.2
Tavella, R.3
Weekes, A.J.4
Morgan, C.5
Beltrame, J.F.6
-
9
-
-
70350129073
-
Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: A comparison of sub-groups by age
-
Rahilly-Tierney CR, Lawler EV, Scranton RE, Gaziano JM. Cardiovascular benefit of magnitude of low-density lipoprotein cholesterol reduction: a comparison of sub-groups by age. Circulation 2009; 120: 1491-7.
-
(2009)
Circulation
, vol.120
, pp. 1491-1497
-
-
Rahilly-Tierney, C.R.1
Lawler, E.V.2
Scranton, R.E.3
Gaziano, J.M.4
-
10
-
-
85031966150
-
Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: The population-based AGESReykjavik Study
-
Olafsdottir E, Aspelund T, Sigurdsson G, et al. Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGESReykjavik Study. BMJ Open 2011; 1: e000132.
-
(2011)
BMJ Open
, vol.1
-
-
Olafsdottir, E.1
Aspelund, T.2
Sigurdsson, G.3
-
11
-
-
0036023515
-
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
-
Athyros VG, Papageorgiou AA, Mercouris BR, et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 2002; 18: 220-8.
-
(2002)
Curr Med Res Opin
, vol.18
, pp. 220-228
-
-
Athyros, V.G.1
Papageorgiou, A.A.2
Mercouris, B.R.3
-
12
-
-
0035897696
-
The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
-
The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
13
-
-
0037145887
-
Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients
-
DOI 10.1016/S0735-1097(02)02477-4, PII S0735109702024774
-
Allen Maycock CA, Muhlestein JB, Horne BD, et al.; Intermountain Heart Collaborative Study. Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. J Am Coll Cardiol 2002; 40: 1777-85. (Pubitemid 35341956)
-
(2002)
Journal of the American College of Cardiology
, vol.40
, Issue.10
, pp. 1777-1785
-
-
Allen, M.C.A.1
Muhlestein, J.B.2
Horne, B.D.3
Carlquist, J.F.4
Bair, T.L.5
Pearson, R.R.6
Li, Q.7
Anderson, J.L.8
-
14
-
-
0033598089
-
Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study
-
DOI 10.1001/archinte.159.15.1785
-
Culleton BF, Larson MG, Evans JC, et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med 1999; 159: 1785-90. (Pubitemid 29379143)
-
(1999)
Archives of Internal Medicine
, vol.159
, Issue.15
, pp. 1785-1790
-
-
Culleton, B.F.1
Larson, M.G.2
Evans, J.C.3
Wilson, P.W.F.4
Barrett, B.J.5
Parfrey, P.S.6
Levy, D.7
-
15
-
-
0032229826
-
Epidemiology of cardiovascular disease in chronic renal disease
-
Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 (12 Suppl): S16-23.
-
(1998)
J Am Soc Nephrol
, vol.9
, Issue.12 SUPPL.
-
-
Foley, R.N.1
Parfrey, P.S.2
Sarnak, M.J.3
-
16
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
17
-
-
20844432360
-
Atherosclerotic risk factors and renal function in the elderly: The role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA)
-
DOI 10.1093/ndt/gfh553
-
Baggio B, Budakovic A, Perissinotto E, et al.; ILSA Working Group. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 2005; 20: 114-23. (Pubitemid 40207615)
-
(2005)
Nephrology Dialysis Transplantation
, vol.20
, Issue.1
, pp. 114-123
-
-
Baggio, B.1
Budakovic, A.2
Perissinotto, E.3
Maggi, S.4
Cantaro, S.5
Enzi, G.6
Grigoletto, F.7
Baldereschi, M.8
Di, C.A.9
Scarlato, G.10
Candelise, L.11
Scarpini, E.12
Battistin, L.13
Bressan, A.14
Bortolan, G.15
Loeb, C.16
Gandolfo, C.17
Canal, N.18
Franceschi, M.19
Ghetti, A.20
Vergassola, R.21
Inzitari, D.22
Bonaiuto, S.23
Fini, F.24
Vesprini, A.25
Cruciani, G.26
Capurso, A.27
Livrea, P.28
Lepore, V.29
Motta, L.30
Carnazzo, G.31
Rengo, F.32
more..
-
18
-
-
12244269700
-
Level of kidney function as a risk factor for cardiovascular outcomes in the elderly
-
DOI 10.1046/j.1523-1755.2003.00838.x
-
Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63: 1121-9. (Pubitemid 36315592)
-
(2003)
Kidney International
, vol.63
, Issue.3
, pp. 1121-1129
-
-
Manjunath, G.1
Tighiouart, H.2
Coresh, J.3
MacLeod, B.4
Salem, D.N.5
Griffith, J.L.6
Levey, A.S.7
Sarnak, M.J.8
-
19
-
-
1542298565
-
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
-
DOI 10.1136/jcp.2003.012989
-
Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A sub-group analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 2004; 57: 728-34. (Pubitemid 38901488)
-
(2004)
Journal of Clinical Pathology
, vol.57
, Issue.7
, pp. 728-734
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Papageorgiou, A.A.3
Symeonidis, A.N.4
Pehlivanidis, A.N.5
Bouloukos, V.I.6
Elisaf, M.7
-
20
-
-
41549159287
-
Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease. The TNT (Treating to New Targets) Study
-
DOI 10.1016/j.jacc.2007.11.072, PII S0735109708003549
-
Shepherd J, Kastelein JJ, Bittner V, et al.; TNT (Treating to New Targets) Investigators. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. J Am Coll Cardiol 2008; 51: 1448-54. (Pubitemid 351471787)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.15
, pp. 1448-1454
-
-
Shepherd, J.1
Kastelein, J.J.P.2
Bittner, V.3
Deedwania, P.4
Breazna, A.5
Dobson, S.6
Wilson, D.J.7
Zuckerman, A.8
Wenger, N.K.9
-
21
-
-
38449119409
-
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
-
Treating to New Targets Investigators
-
Shepherd J, Kastelein JJ, Bittner V, et al.; Treating to New Targets Investigators. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol 2007; 2: 1131-9.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 1131-1139
-
-
Shepherd, J.1
Kastelein, J.J.2
Bittner, V.3
-
22
-
-
79960430739
-
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome A post hoc analysis of the ATTEMPT study
-
the Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group
-
Athyros VG, Karagiannis A, Ganotakis ES, et al.; the Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome A post hoc analysis of the ATTEMPT study. Curr Med Res Opin 2011; 27: 1659-68.
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 1659-1668
-
-
Athyros, V.G.1
Karagiannis, A.2
Ganotakis, E.S.3
-
23
-
-
84855392114
-
IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
-
IMPERATIVE Collaborative Group
-
Athyros VG, Hatzitolios AI, Karagiannis A, et al.; IMPERATIVE Collaborative Group. IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch Med Sci 2011; 7: 984-92.
-
(2011)
Arch Med Sci
, vol.7
, pp. 984-992
-
-
Athyros, V.G.1
Hatzitolios, A.I.2
Karagiannis, A.3
-
24
-
-
33847629876
-
Statins and renal function. Is the compound and dose making a difference? [15]
-
DOI 10.1093/ndt/gfl802
-
Athyros VG, Karagiannis A, Kakafika A, Elisaf M, Mikhailidis DP. Statins and renal function. Is the com pound and dose making a difference? Nephrol Dial Transplant 2007; 22: 963-4. (Pubitemid 46351732)
-
(2007)
Nephrology Dialysis Transplantation
, vol.22
, Issue.3
, pp. 963-964
-
-
Athyros, V.G.1
Karagiannis, A.2
Kakafika, A.3
Elisaf, M.4
Mikhailidis, D.P.5
-
26
-
-
80052554967
-
Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate
-
Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Iaina-Levin N, Kobus G, Dobrzycki S. Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate. Arch Med Sci 2011; 7: 658-64.
-
(2011)
Arch Med Sci
, vol.7
, pp. 658-664
-
-
Malyszko, J.1
Bachorzewska-Gajewska, H.2
Malyszko, J.3
Iaina-Levin, N.4
Kobus, G.5
Dobrzycki, S.6
-
27
-
-
85047692424
-
Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia
-
Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973; 132: 401-10.
-
(1973)
Arch Intern Med
, vol.132
, pp. 401-410
-
-
Klein, R.1
Klein, B.E.2
Cornoni, J.C.3
Maready, J.4
Cassel, J.C.5
Tyroler, H.A.6
-
28
-
-
0033529386
-
Serum uric acid and risk for cardiovascular disease and death: The Framingham heart study
-
Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 1999; 131: 7-13. (Pubitemid 29310011)
-
(1999)
Annals of Internal Medicine
, vol.131
, Issue.1
, pp. 7-13
-
-
Culleton, B.F.1
Larson, M.G.2
Kannel, W.B.3
Levy, D.4
-
29
-
-
0034630917
-
Serum uric acid and cardiovascular mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
-
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-10. (Pubitemid 30257539)
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.18
, pp. 2404-2410
-
-
Fang, J.1
Alderman, M.H.2
-
30
-
-
39749157632
-
Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A Preventive Cardiology Information System (PreCIS) database cohort study
-
DOI 10.1002/art.23121
-
Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology infor mation system (PreCIS) database cohort study. Arthritis Rheum 2008; 58: 623-30. (Pubitemid 351294901)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.2
, pp. 623-630
-
-
Ioachimescu, A.G.1
Brennan, D.M.2
Hoar, B.M.3
Hazen, S.L.4
Hoogwerf, B.J.5
-
31
-
-
62549112964
-
Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A Chinese cohort study
-
Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009; 61: 225-32.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 225-232
-
-
Chen, J.H.1
Chuang, S.Y.2
Chen, H.J.3
Yeh, W.T.4
Pan, W.H.5
-
33
-
-
79960411842
-
Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): A relationship with implications for vascular risk?
-
Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk? Curr Vasc Pharmacol 2011; 9: 698-705.
-
(2011)
Curr Vasc Pharmacol
, vol.9
, pp. 698-705
-
-
Katsiki, N.1
Athyros, V.G.2
Karagiannis, A.3
Mikhailidis, D.P.4
-
34
-
-
34347230840
-
Serum uric acid as an independent predictor of early death after acute stroke
-
DOI 10.1253/circj.71.1120
-
Karagiannis A, Mikhailidis DP, Tziomalos K, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J 2007; 71: 1120-7. (Pubitemid 46998030)
-
(2007)
Circulation Journal
, vol.71
, Issue.7
, pp. 1120-1127
-
-
Karagiannis, A.1
Mikhailidis, D.P.2
Tziomalos, K.3
Sileli, M.4
Savvatianos, S.5
Kakafika, A.6
Gossios, T.7
Krikis, N.8
Moschou, I.9
Xochellis, M.10
Athyros, V.G.11
-
35
-
-
2442513706
-
Uric acid levels and vascular disease
-
DOI 10.1185/030079904125003971
-
Daskalopoulou SS, Athyros VG, Elisaf M, Mikhailidis DP. Uric acid levels and vascular disease. Curr Med Res Opin 2004; 20: 951-4. (Pubitemid 38821534)
-
(2004)
Current Medical Research and Opinion
, vol.20
, Issue.6
, pp. 951-954
-
-
Daskalopoulou, S.S.1
Athyros, V.G.2
Elisaf, M.3
Mikhailidis, D.P.4
-
36
-
-
0036147865
-
Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease
-
DOI 10.1016/S0002-9149(01)02155-5, PII S0002914901021555
-
Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 2002; 89: 12-7. (Pubitemid 34066579)
-
(2002)
American Journal of Cardiology
, vol.89
, Issue.1
, pp. 12-17
-
-
Bickel, C.1
Rupprecht, H.J.2
Blankenberg, S.3
Rippin, G.4
Hafner, G.5
Daunhauer, A.6
Hofmann, K.-P.7
Meyer, J.8
-
37
-
-
84873704608
-
Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease?
-
Epub ahead of print
-
Eisen A, Benderly M, Goldbourt U, Haim M. Is serum uric acid level an independent predictor of heart failure among patients with coronary artery disease? Clin Cardiol 2013 Epub ahead of print.
-
(2013)
Clin Cardiol
-
-
Eisen, A.1
Benderly, M.2
Goldbourt, U.3
Haim, M.4
-
38
-
-
65649116888
-
Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: Sub-analysis of the Japanese Coronary Artery Disease (JCAD) Study
-
Japanese Coronary Artery Disease Study Investigators
-
Okura T, Higaki J, Kurata M, et al.; Japanese Coronary Artery Disease Study Investigators. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: sub-analysis of the Japanese Coronary Artery Disease (JCAD) Study. Circ J 2009; 73: 885-91.
-
(2009)
Circ J
, vol.73
, pp. 885-891
-
-
Okura, T.1
Higaki, J.2
Kurata, M.3
-
39
-
-
1542268611
-
Effect of Statins Versus Untreated Dyslipidemia on Serum Uric Acid Levels in Patients with Coronary Heart Disease: A Subgroup Analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
-
DOI 10.1053/j.ajkd.2003.12.023
-
Athyros VG, Elisaf M, Papageorgiou AA, et al.; GREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis 2004; 43: 589-99. (Pubitemid 38401873)
-
(2004)
American Journal of Kidney Diseases
, vol.43
, Issue.4
, pp. 589-599
-
-
Athyros, V.G.1
Elisaf, M.2
Papageorgiou, A.A.3
Symeonidis, A.N.4
Pehlivanidis, A.N.5
Bouloukos, V.I.6
Milionis, H.J.7
Mikhailidis, D.P.8
-
40
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
DOI 10.1053/jhep.2003.50161
-
Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23. (Pubitemid 36397405)
-
(2003)
Hepatology
, vol.37
, Issue.4
, pp. 917-923
-
-
Marchesini, G.1
Bugianesi, E.2
Forlani, G.3
Cerrelli, F.4
Lenzi, M.5
Manini, R.6
Natale, S.7
Vanni, E.8
Villanova, N.9
Melchionda, N.10
Rizzetto, M.11
-
41
-
-
34547732002
-
GI epidemiology: Nonalcoholic fatty liver disease
-
Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25: 883-9.
-
(2007)
Aliment Pharmacol Ther
, vol.25
, pp. 883-889
-
-
Angulo, P.1
-
42
-
-
33747517955
-
The epidemiology of nonalcoholic fatty liver disease in adults
-
Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40 (Suppl 1): S5-10.
-
(2006)
J Clin Gastroenterol
, vol.40
, Issue.SUPPL. 1
-
-
Clark, J.M.1
-
43
-
-
84869224505
-
Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study
-
Koehler EM, Schouten JN, Hansen BE, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol 2012; 57: 1305-11.
-
(2012)
J Hepatol
, vol.57
, pp. 1305-1311
-
-
Koehler, E.M.1
Schouten, J.N.2
Hansen, B.E.3
-
44
-
-
75449088414
-
Decreased survival of subjects with elevated liver function tests during a 28-follow-up
-
Söderberg C, Stå l P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-follow-up. Hepatology 2010; 51: 595-602.
-
(2010)
Hepatology
, vol.51
, pp. 595-602
-
-
Söderberg, C.1
Stå L, P.2
Askling, J.3
-
45
-
-
0035085853
-
Clinical features and natural history of nonalcoholic steatosis syndromes
-
Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21: 17-26. (Pubitemid 32240483)
-
(2001)
Seminars in Liver Disease
, vol.21
, Issue.1
, pp. 17-26
-
-
Falck-Ytter, Y.1
Younossi, Z.M.2
Marchesini, G.3
McCullough, A.J.4
-
46
-
-
78649890465
-
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
-
GREACE Study Collaborative Group
-
Athyros VG, Tziomalos K, Gossios TD, et al.; GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010; 376: 1916-22.
-
(2010)
Lancet
, vol.376
, pp. 1916-1922
-
-
Athyros, V.G.1
Tziomalos, K.2
Gossios, T.D.3
-
47
-
-
81555203011
-
Safety and impact on cardiovascular events of long-term multi-factorial treatment in patients with metabolic syndrome and abnormal liver function tests: A post hoc analysis of the randomised ATTEMPT study
-
Athyros VG, Giouleme O, Ganotakis ES, et al. Safety and impact on cardiovascular events of long-term multi-factorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci 2011; 7: 796-805.
-
(2011)
Arch Med Sci
, vol.7
, pp. 796-805
-
-
Athyros, V.G.1
Giouleme, O.2
Ganotakis, E.S.3
-
48
-
-
84863987606
-
Smoking and non-alcoholic steatohepatitis (NASH): The GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial
-
Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial. J Hepatol 2012; 57: 476.
-
(2012)
J Hepatol
, vol.57
, pp. 476
-
-
Katsiki, N.1
Athyros, V.G.2
Karagiannis, A.3
Mikhailidis, D.P.4
-
49
-
-
33745046866
-
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: A randomised study
-
DOI 10.1185/030079906X104696
-
Athyros VG, Mikhailidis DP, Didangelos TP, et al. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med Res Opin 2006; 22: 873-83. (Pubitemid 43875555)
-
(2006)
Current Medical Research and Opinion
, vol.22
, Issue.5
, pp. 873-883
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
Didangelos, T.P.3
Giouleme, O.I.4
Liberopoulos, E.N.5
Karagiannis, A.6
Kakafika, A.I.7
Tziomalos, K.8
Burroughs, A.K.9
Elisaf, M.S.10
-
50
-
-
33746453316
-
Statins for non-alcoholic fatty liver disease: A new indication? [3]
-
DOI 10.1111/j.1365-2036.2006.03021.x
-
Liberopoulos EN, Athyros VG, Elisaf MS, Mikhailidis DP. Statins for non-alcoholic fatty liver disease: a new indication? Aliment Pharmacol Ther 2006; 24: 698-9. (Pubitemid 44127854)
-
(2006)
Alimentary Pharmacology and Therapeutics
, vol.24
, Issue.4
, pp. 698-699
-
-
Liberopoulos, E.N.1
Athyros, V.G.2
Elisaf, M.S.3
Mikhailidis, D.P.4
-
51
-
-
79953880237
-
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?
-
Athyros VG, Tziomalos K, Daskalopoulos GN, Karagiannis A, Mikhailidis DP. Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med 2011; 43: 167-71.
-
(2011)
Ann Med
, vol.43
, pp. 167-171
-
-
Athyros, V.G.1
Tziomalos, K.2
Daskalopoulos, G.N.3
Karagiannis, A.4
Mikhailidis, D.P.5
-
53
-
-
84857132090
-
Non-alcoholic fatty liver disease in type 2 diabetes: Pathogenesis and treatment options
-
Tziomalos K, Athyros VG, Karagiannis A. Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. Curr Vasc Pharmacol 2012; 10: 162-72.
-
(2012)
Curr Vasc Pharmacol
, vol.10
, pp. 162-172
-
-
Tziomalos, K.1
Athyros, V.G.2
Karagiannis, A.3
-
54
-
-
84861869259
-
Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: A post hoc ATTEMPT analysis
-
Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group
-
Athyros VG, Elisaf MS, Alexandrides T, et al. Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology 2012; 63; 358-66.
-
(2012)
Angiology
, vol.63
, pp. 358-366
-
-
Athyros, V.G.1
Elisaf, M.S.2
Alexandrides, T.3
-
55
-
-
84865147415
-
Pharmacotherapy: Statins and new-onset diabetes mellitus: A matter for debate
-
Athyros VG, Mikhailidis DP. Pharmacotherapy: statins and new-onset diabetes mellitus: a matter for debate. Nat Rev Endocrinol 2012; 8: 133-4.
-
(2012)
Nat Rev Endocrinol
, vol.8
, pp. 133-134
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
-
56
-
-
84871014821
-
Patient with hyper triglyceridemia, type 2 diabetes, and chronic kidney disease treated with atorvastatin and omega-3 fatty acid ethyl esters
-
Athyros VG, Mikhailidis DP. Patient with hyper triglyceridemia, type 2 diabetes, and chronic kidney disease treated with atorvastatin and omega-3 fatty acid ethyl esters. Open Cardiovasc Med J 2012; 6: 122-5.
-
(2012)
Open Cardiovasc Med J
, vol.6
, pp. 122-125
-
-
Athyros, V.G.1
Mikhailidis, D.P.2
-
57
-
-
82855161011
-
Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: The case for residual risk reduction after statin treatment
-
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment. Open Cardiovasc Med J 2011; 5: 24-34.
-
(2011)
Open Cardiovasc Med J
, vol.5
, pp. 24-34
-
-
Athyros, V.G.1
Tziomalos, K.2
Karagiannis, A.3
Mikhailidis, D.P.4
-
58
-
-
0344442802
-
Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus
-
Athyros VG, Papageorgiou AA, Symeonidis AN, et al.; GREACE Study Collaborative Group. Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus. Angiology 2003; 54: 679-90. (Pubitemid 37463265)
-
(2003)
Angiology
, vol.54
, Issue.6
, pp. 679-690
-
-
Athyros, V.G.1
Papageorgiou, A.A.2
Symeonidis, A.N.3
Didangelos, T.P.4
Pehlivanidis, A.N.5
Bouloukos, V.I.6
Mikhailidis, D.P.7
-
59
-
-
33746428470
-
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: The Treating To New Targets (TNT) study
-
DOI 10.2337/dc05-2465
-
Shepherd J, Barter P, Carmena R, et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care 2006; 29: 1220-6. (Pubitemid 44125913)
-
(2006)
Diabetes Care
, vol.29
, Issue.6
, pp. 1220-1226
-
-
Shepherd, J.1
Barter, P.2
Carmena, R.3
Deedwania, P.4
Fruchart, J.-C.5
Haffner, S.6
Hsia, J.7
Breazna, A.8
LaRosa, J.9
Grundy, S.10
Waters, D.11
-
60
-
-
84876745686
-
The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: A post hoc analysis of the GREACE Study
-
the GREACE Study Collaborative Group Epub ahead of print
-
Athyros VG, Tziomalos K, Katsiki N, et al.; the GREACE Study Collaborative Group. The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE Study. Curr Vasc Pharmacol 2012 Epub ahead of print.
-
(2012)
Curr Vasc Pharmacol
-
-
Athyros, V.G.1
Tziomalos, K.2
Katsiki, N.3
-
61
-
-
0034829791
-
Smoking diminishes the beneficial effect of statins: Observations from the landmark trials
-
Milionis HJ, Rizos E, Mikhailidis DP. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology 2001; 52: 575-87. (Pubitemid 32880107)
-
(2001)
Angiology
, vol.52
, Issue.9
, pp. 575-587
-
-
Milionis, H.J.1
Rizos, E.2
Mikhailidis, D.P.3
-
63
-
-
84855377503
-
Lipids, blood pressure, kidney - What was new in 2011?
-
Barylski M, Małyszko J, Rysz J, Myśliwiec M, Banach M. Lipids, blood pressure, kidney - what was new in 2011? Arch Med Sci 2011; 7: 1055-66.
-
(2011)
Arch Med Sci
, vol.7
, pp. 1055-1066
-
-
Barylski, M.1
Małyszko, J.2
Rysz, J.3
Myśliwiec, M.4
Banach, M.5
|